Skip to main content
BC

Bilal Chughtai

🏥 Northwell Health, New York, NY
Mentored by · fellowship 2012
Steven A. Kaplan

Biography​

He is an associate professor of urology at the Zucker School of Medicine at Hofstra/Northwell.1

Contributions​

His cited work covers benign prostatic hyperplasia treatments, including the iTind device, prostatic urethral lift, photoselective vaporization, Rezūm therapy, and simple prostatectomy. Other cited studies examine outcomes of sling and prolapse mesh implants and treatments for overactive bladder.23456

Cited on WARWIKI

10 publications with Bilal Chughtai as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.

  1. Chughtai B, Elterman D, Shore N, et al. "The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial." Urology. 2021;153:270–6. doi
    Cited on: iTind — Temporary Implantable Nitinol Device · iTIND — Temporary Implantable Nitinol Device for BPH
  2. Chughtai B, Mao J, Matheny ME, et al. Long-Term Safety With Sling Mesh Implants for Stress Incontinence. The Journal of Urology. 2021;205(1):183-190. doi
    Cited on: Polypropylene Mesh · Female Slings & Suspensions
  3. Miller LE, Chughtai B, Dornbier RA, McVary KT. Surgical reintervention rate after prostatic urethral lift: systematic review and meta-analysis involving over 2,000 patients. J Urol. 2020;204(5):1019-1026. doi
    Cited on: Optilume BPH — Paclitaxel-Coated Balloon for LUTS Secondary to BPH · UroLift — Prostatic Urethral Lift (PUL) for BPH
  4. Elterman D, Bhojani N, Vannabouathong C, Chughtai B, Zorn KC. Large, multi-center, prospective registry of Rezūm water vapor therapy for benign prostatic hyperplasia. Urology. 2022;165:261–267. doi
    Cited on: Rezūm — Water Vapor Thermal Therapy (WVTT) for BPH
  5. Chughtai B, Clemens JQ, Thomas D, et al. "Real World Performance of Sacral Neuromodulation and OnabotulinumtoxinA for Overactive Bladder: Focus on Safety and Cost." J Urol. 2020;203(1):179–184. doi
    Cited on: Intradetrusor OnabotulinumtoxinA
  6. Chughtai B, Mao J, Asfaw TS, et al. Long-term device outcomes of mesh implants in pelvic organ prolapse repairs. Obstet Gynecol. 2020;135(3):591-598. doi
    Cited on: Mesh & Graft-Augmented Prolapse Repair
  7. Chughtai B, Forde JC, Thomas DD, et al. "Benign Prostatic Hyperplasia." Nat Rev Dis Primers. 2016;2:16031. doi
    Cited on: Benign Prostatic Hyperplasia
  8. Chughtai B, Spettel S, Kurman J, De E. Ambulatory pessary trial unmasks occult stress urinary incontinence. Obstet Gynecol Int. 2012;2012:392027. doi
    Cited on: POP Overview
  9. Chughtai B, Te A. Photoselective vaporization of the prostate for treating benign prostatic hyperplasia. Expert Rev Med Devices. 2011;8(5):591-595. doi
    Cited on: GreenLight PVP — Photoselective Vaporization of the Prostate
  10. Rehman J, Khan SA, Sukkarieh T, Chughtai B, Waltzer WC. Extraperitoneal laparoscopic prostatectomy (adenomectomy) for obstructing benign prostatic hyperplasia: transvesical and transcapsular (Millin) techniques. J Endourol. 2005;19(4):491–496. doi
    Cited on: Simple Prostatectomy (Open / Laparoscopic / Robotic)

Footnotes​

  1. Dr. Chughtai Supports New FDA Approval For Oral Utebzi for Patients with Complicated UTIs. Accessed October 2026. ↩

  2. Chughtai B, Elterman D, Shore N, et al. "The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial." Urology. 2021;153:270–6. doi:10.1016/j.urology.2020.12.022 ↩

  3. Miller LE, Chughtai B, Dornbier RA, McVary KT. Surgical reintervention rate after prostatic urethral lift: systematic review and meta-analysis involving over 2,000 patients. J Urol. 2020;204(5):1019-1026. doi:10.1097/ju.0000000000001132 ↩

  4. Chughtai B, Mao J, Matheny ME, et al. Long-Term Safety With Sling Mesh Implants for Stress Incontinence. The Journal of Urology. 2021;205(1):183-190. doi:10.1097/ju.0000000000001312 ↩

  5. Chughtai B, Forde JC, Thomas DD, et al. "Benign Prostatic Hyperplasia." Nat Rev Dis Primers. 2016;2:16031. doi:10.1038/nrdp.2016.31 ↩

  6. Chughtai B, Mao J, Matheny ME, et al. "Long-Term Safety With Sling Mesh Implants for Stress Incontinence." J Urol. 2021;205(1):183-190. doi:10.1097/ju.0000000000001312 ↩